NCT06325748 2026-02-12SENTI-202: Off-the-shelf Logic Gated CAR NK Cell Therapy in Adults With CD33 and/or FLT3 Blood Cancers Including AML/MDSSenti BiosciencesPhase 1 Active not recruiting21 enrolled